SFDA with New Medical Device Marketing Authorization (MDMA) and Fast Track Fee

Jul 4, 20181 min read

The Saudi Food and Drug Authority (SFDA) informs medical devices manufacturers and their Authorized Representatives that Marketing Authorization fess (MDMA) has been updated according to the table below:

Notes:

New fees take into account number of products in the application regardless of devices risk classification.
Devices accessories are counted within the number of products
Application shall comply with SFDA criteria of Bundled devices.

SFDA is also introducing Fast track service. This new propose fees will be in place soon.

Recent Posts

See All

Saudi Arabia: SFDA Introduces New Permit Service for Travellers Carrying Controlled Drugs

Saudi Arabia SFDA: New Online System GHAD Replacing Old System Hits The Local Registrants

Announcement made by Saudi Arabia SFDA in August hits the local registrants. In-country representatives as SFDA are closing all the...

Asia, Africa & Middle East - Aug 2019

Australia: 2019 fees and charges released by the Therapeutic Goods Administration Australia: Conformity assessment standards for medical...

SFDA with New Medical Device Marketing Authorization (MDMA) and Fast Track Fee

Recent Posts

Comments